Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -220 | -226 | -1,060 | -870 | -620 |
| Depreciation Amortization | 20 | 24 | 30 | 220 | 10 |
| Accounts receivable | N/A | -1 | N/A | N/A | N/A |
| Other Working Capital | 160 | 165 | 150 | 50 | 60 |
| Other Operating Activity | 10 | 1 | -30 | -20 | -30 |
| Operating Cash Flow | $-30 | $-38 | $-910 | $-620 | $-580 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | -10 | -20 | -10 |
| Investing Cash Flow | $0 | $N/A | $-10 | $-20 | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 25 | N/A | N/A | N/A |
| Other Financing Activity | 20 | 0 | 870 | 830 | 530 |
| Financing Cash Flow | $20 | $25 | $870 | $830 | $530 |
| Beginning Cash Position | 10 | 13 | 70 | 70 | 70 |
| End Cash Position | 1 | 1 | 10 | 60 | 0 |
| Net Cash Flow | $-10 | $-13 | $-50 | $-9 | $-70 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30 | -38 | -910 | -620 | -580 |
| Free Cash Flow | -30 | -38 | -910 | -620 | -580 |